Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Influenza Vaccine Revenue 2016-2027
2.1.2 Global Influenza Vaccine Sales 2016-2027
2.2 Influenza Vaccine Market Size by Region: 2021 Versus 2027
2.3 Influenza Vaccine Sales by Region (2016-2027)
2.3.1 Global Influenza Vaccine Sales by Region: 2016-2021
2.3.2 Global Influenza Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Influenza Vaccine Sales Market Share by Region (2016-2027)
2.4 Influenza Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Vaccine Revenue by Region: 2016-2021
2.4.2 Global Influenza Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Influenza Vaccine Revenue Market Share by Region (2016-2027)
3 Global Influenza Vaccine by Manufacturers
3.1 Global Top Influenza Vaccine Manufacturers by Sales
3.1.1 Global Influenza Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Influenza Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Influenza Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Influenza Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Influenza Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Influenza Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Influenza Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CSL
4.1.1 CSL Corporation Information
4.1.2 CSL Description, Business Overview
4.1.3 CSL Influenza Vaccine Products Offered
4.1.4 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 CSL Influenza Vaccine Revenue by Product
4.1.6 CSL Influenza Vaccine Revenue by Application
4.1.7 CSL Influenza Vaccine Revenue by Geographic Area
4.1.8 CSL Influenza Vaccine Revenue by Sales Channel
4.1.9 CSL Recent Development
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Influenza Vaccine Products Offered
4.2.4 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 GSK Influenza Vaccine Revenue by Product
4.2.6 GSK Influenza Vaccine Revenue by Application
4.2.7 GSK Influenza Vaccine Revenue by Geographic Area
4.2.8 GSK Influenza Vaccine Revenue by Sales Channel
4.2.9 GSK Recent Development
4.3 Sanofi Pasteur
4.3.1 Sanofi Pasteur Corporation Information
4.3.2 Sanofi Pasteur Description, Business Overview
4.3.3 Sanofi Pasteur Influenza Vaccine Products Offered
4.3.4 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Sanofi Pasteur Influenza Vaccine Revenue by Product
4.3.6 Sanofi Pasteur Influenza Vaccine Revenue by Application
4.3.7 Sanofi Pasteur Influenza Vaccine Revenue by Geographic Area
4.3.8 Sanofi Pasteur Influenza Vaccine Revenue by Sales Channel
4.3.9 Sanofi Pasteur Recent Development
4.4 Mylan
4.4.1 Mylan Corporation Information
4.4.2 Mylan Description, Business Overview
4.4.3 Mylan Influenza Vaccine Products Offered
4.4.4 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Mylan Influenza Vaccine Revenue by Product
4.4.6 Mylan Influenza Vaccine Revenue by Application
4.4.7 Mylan Influenza Vaccine Revenue by Geographic Area
4.4.8 Mylan Influenza Vaccine Revenue by Sales Channel
4.4.9 Mylan Recent Development
4.5 Hulan Bio
4.5.1 Hulan Bio Corporation Information
4.5.2 Hulan Bio Description, Business Overview
4.5.3 Hulan Bio Influenza Vaccine Products Offered
4.5.4 Hulan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Hulan Bio Influenza Vaccine Revenue by Product
4.5.6 Hulan Bio Influenza Vaccine Revenue by Application
4.5.7 Hulan Bio Influenza Vaccine Revenue by Geographic Area
4.5.8 Hulan Bio Influenza Vaccine Revenue by Sales Channel
4.5.9 Hulan Bio Recent Development
4.6 AstraZeneca
4.6.1 AstraZeneca Corporation Information
4.6.2 AstraZeneca Description, Business Overview
4.6.3 AstraZeneca Influenza Vaccine Products Offered
4.6.4 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 AstraZeneca Influenza Vaccine Revenue by Product
4.6.6 AstraZeneca Influenza Vaccine Revenue by Application
4.6.7 AstraZeneca Influenza Vaccine Revenue by Geographic Area
4.6.8 AstraZeneca Recent Development
4.7 CCBIO
4.7.1 CCBIO Corporation Information
4.7.2 CCBIO Description, Business Overview
4.7.3 CCBIO Influenza Vaccine Products Offered
4.7.4 CCBIO Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.7.5 CCBIO Influenza Vaccine Revenue by Product
4.7.6 CCBIO Influenza Vaccine Revenue by Application
4.7.7 CCBIO Influenza Vaccine Revenue by Geographic Area
4.7.8 CCBIO Recent Development
5 Breakdown Data by Type
5.1 Global Influenza Vaccine Sales by Type (2016-2027)
5.1.1 Global Influenza Vaccine Sales by Type (2016-2021)
5.1.2 Global Influenza Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Influenza Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Influenza Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Influenza Vaccine Revenue by Type (2016-2021)
5.2.2 Global Influenza Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Influenza Vaccine Revenue Market Share by Type (2016-2027)
5.3 Influenza Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Influenza Vaccine Sales by Application (2016-2027)
6.1.1 Global Influenza Vaccine Sales by Application (2016-2021)
6.1.2 Global Influenza Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Influenza Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Influenza Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Influenza Vaccine Revenue by Application (2016-2021)
6.2.2 Global Influenza Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Influenza Vaccine Revenue Market Share by Application (2016-2027)
6.3 Influenza Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Influenza Vaccine Market Size YoY Growth 2016-2027
7.2 North America Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Influenza Vaccine Sales by Country (2016-2027)
7.2.2 North America Influenza Vaccine Revenue by Country (2016-2027)
7.3 North America Influenza Vaccine Sales by Type
7.4 North America Influenza Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Influenza Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Influenza Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Influenza Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Influenza Vaccine Sales by Type
8.4 Asia-Pacific Influenza Vaccine Sales by Application
9 Europe
9.1 Europe Influenza Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Influenza Vaccine Market Facts & Figures by Country
9.2.1 Europe Influenza Vaccine Sales by Country (2016-2027)
9.2.2 Europe Influenza Vaccine Revenue by Country (2016-2027)
9.3 Europe Influenza Vaccine Sales by Type
9.4 Europe Influenza Vaccine Sales by Application
10 Latin America
10.1 Latin America Influenza Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Influenza Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Influenza Vaccine Revenue by Country (2016-2027)
10.3 Latin America Influenza Vaccine Sales by Type
10.4 Latin America Influenza Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Influenza Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Influenza Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Influenza Vaccine Sales by Type
11.4 Middle East and Africa Influenza Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Influenza Vaccine Supply Chain Analysis
12.2 Influenza Vaccine Key Raw Materials and Upstream Suppliers
12.3 Influenza Vaccine Clients Analysis
12.4 Influenza Vaccine Sales Channel and Sales Model Analysis
12.4.1 Influenza Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Influenza Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Influenza Vaccine Distributors
13 Market Dynamics
13.1 Influenza Vaccine Market Drivers
13.2 Influenza Vaccine Market Opportunities
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Influenza Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 5. Global Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2027
Table 6. Global Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
Table 7. Global Influenza Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 8. Global Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 9. Global Influenza Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 10. Global Influenza Vaccine Sales by Manufacturer (2016-2021) & (M Doses)
Table 11. Global Influenza Vaccine Sales Share by Manufacturer (2016-2021)
Table 12. Influenza Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 13. Influenza Vaccine Revenue Share by Manufacturer (2016-2021)
Table 14. Key Manufacturers Influenza Vaccine Price (2016-2021) & (USD/Doses)
Table 15. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 17. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2020)
Table 18. Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Influenza Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Influenza Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. CSL Corporation Information
Table 23. CSL Description and Business Overview
Table 24. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 25. CSL Influenza Vaccine Product
Table 26. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 27. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 28. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 29. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 30. CSL Recent Development
Table 31. GSK Corporation Information
Table 32. GSK Description and Business Overview
Table 33. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 34. GSK Influenza Vaccine Product
Table 35. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 36. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 37. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 38. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 39. GSK Recent Development
Table 40. Sanofi Pasteur Corporation Information
Table 41. Sanofi Pasteur Description and Business Overview
Table 42. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 43. Sanofi Pasteur Influenza Vaccine Product
Table 44. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 45. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 46. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 47. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 48. Sanofi Pasteur Recent Development
Table 49. Mylan Corporation Information
Table 50. Mylan Description and Business Overview
Table 51. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 52. Mylan Influenza Vaccine Product
Table 53. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 54. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 55. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Mylan Recent Development
Table 58. Hulan Bio Corporation Information
Table 59. Hulan Bio Description and Business Overview
Table 60. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 61. Hulan Bio Influenza Vaccine Product
Table 62. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 63. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 64. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Hulan Bio Recent Development
Table 67. AstraZeneca Corporation Information
Table 68. AstraZeneca Description and Business Overview
Table 69. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 70. AstraZeneca Influenza Vaccine Product
Table 71. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 72. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 73. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 74. AstraZeneca Recent Development
Table 75. CCBIO Corporation Information
Table 76. CCBIO Description and Business Overview
Table 77. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 78. CCBIO Influenza Vaccine Product
Table 79. CCBIO Influenza Vaccine Revenue (US$ Million) and Market Share by Product
Table 80. CCBIO Influenza Vaccine Revenue (US$ Million) and Market Share by Application
Table 81. CCBIO Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 82. CCBIO Recent Development
Table 83. Global Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
Table 84. Global Influenza Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 85. Global Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 86. Global Influenza Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 87. Global Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
Table 88. Global Influenza Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 89. Global Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 90. Global Influenza Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 91. North America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 92. North America Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
Table 93. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 94. North America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 95. North America Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
Table 96. North America Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
Table 97. Asia-Pacific Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
Table 98. Asia-Pacific Influenza Vaccine Sales by Region (2022-2027) & (M Doses)
Table 99. Asia-Pacific Influenza Vaccine Revenue by Region (2016-2027) & (US$ Million)
Table 100. Asia-Pacific Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 101. Asia-Pacific Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
Table 102. Asia-Pacific Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
Table 103. Europe Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 104. Europe Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
Table 105. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 106. Europe Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 107. Europe Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
Table 108. Europe Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
Table 109. Latin America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 110. Latin America Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
Table 111. Latin America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 112. Latin America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 113. Latin America Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
Table 114. Latin America Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
Table 115. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 116. Middle East and Africa Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
Table 117. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 118. Middle East and Africa Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 119. Middle East and Africa Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
Table 120. Middle East and Africa Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
Table 121. Influenza Vaccine Key Raw Materials, Industry Status and Trend
Table 122. Influenza Vaccine Key Raw Materials and Upstream Suppliers
Table 123. Influenza Vaccine Clients Status and Trend
Table 124. Influenza Vaccine Typical Clients
Table 125. Influenza Vaccine Distributors
Table 126. Key Drivers: Impact Analysis (2022-2027)
Table 127. Influenza Vaccine Market Drivers
Table 128. Influenza Vaccine Market Opportunities
Table 129. Influenza Vaccine Market Challenges
Table 130. Influenza Vaccine Market Restraints
Table 131. Influenza Vaccine Porter's Five Forces Analysis
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. For Children (6 months to 3 years) Examples
Figure 7. For Adults and Children over 3 years Examples
Figure 8. Influenza Vaccine Report Years Considered
Figure 9. Global Influenza Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Influenza Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Influenza Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Influenza Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Influenza Vaccine Sales Market Share Forecast by Region (2016-2027)
Figure 14. Global Influenza Vaccine Revenue Market Share by Region (2016-2027)
Figure 15. Global Influenza Vaccine Sales Share by Manufacturer in 2020
Figure 16. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 17. Global Influenza Vaccine Sales Market Share Forecast by Type (2016-2027)
Figure 18. Global Influenza Vaccine Revenue Market Share Forecast by Type (2016-2027)
Figure 19. Influenza Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 20. Global Influenza Vaccine Sales Market Share Forecast by Application (2016-2027)
Figure 21. Global Influenza Vaccine Revenue Market Share Forecast by Application (2016-2027)
Figure 22. Influenza Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 23. North America Influenza Vaccine Revenue 2016-2027 (US$ Million)
Figure 24. North America Influenza Vaccine Sales Market Share by Type (2016-2021)
Figure 25. North America Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Asia-Pacific Influenza Vaccine Revenue 2016-2027 (US$ Million)
Figure 27. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2016-2027)
Figure 28. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2016-2027)
Figure 29. Asia-Pacific Influenza Vaccine Sales Market Share by Type (2016-2021)
Figure 30. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 31. Europe Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Europe Influenza Vaccine Sales Market Share by Country (2016-2027)
Figure 33. Europe Influenza Vaccine Revenue Market Share by Country (2016-2027)
Figure 34. Europe Influenza Vaccine Sales Market Share by Type (2016-2021)
Figure 35. Europe Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 36. Latin America Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 37. Latin America Influenza Vaccine Sales Market Share by Country (2016-2027)
Figure 38. Latin America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Figure 39. Latin America Influenza Vaccine Sales Market Share by Type (2016-2021)
Figure 40. Latin America Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 41. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 42. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2016-2027)
Figure 43. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2016-2027)
Figure 44. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2016-2021)
Figure 45. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 46. Influenza Vaccine Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Influenza Vaccine Raw Materials by Region in 2020
Figure 48. Influenza Vaccine Distribution Channels
Figure 49. Global Influenza Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 50. Global Influenza Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
Figure 51. Porter's Five Forces Analysis
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs